Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00258453
Other study ID # GPOH-CRANIOPHARYNGIOMA-2000
Secondary ID CDR0000450768EU-
Status Completed
Phase N/A
First received November 22, 2005
Last updated August 1, 2013
Start date May 2001
Est. completion date September 2009

Study information

Verified date October 2007
Source National Cancer Institute (NCI)
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Interventional

Clinical Trial Summary

RATIONALE: Collecting information on how craniopharyngioma is diagnosed and treated may help doctors predict a patient's response to treatment and help plan the best treatment. It may also help identify the intermediate- and long-term effects of treatment.

PURPOSE: This clinical trial is collecting information on diagnosis, treatment, and quality of life of young patients who are undergoing surgery for craniopharyngioma.


Description:

OBJECTIVES:

Primary

- Identify all applied therapy strategies in pediatric patients with craniopharyngioma.

- Correlate relapse status with different therapy strategies/modality in these patients.

- Determine the health status (i.e., ophthalmologic, neuropediatric, and endocrine findings) and the health-related quality of life of these patients after treatment.

Secondary

- Determine the incidence of craniopharyngioma in pediatric patients.

- Identify quality control measures for diagnosis and therapy in these patients.

- Improve long-term care through a standardized follow-up program in these patients.

- Determine the efficacy of endocrine substitution for postoperative hypopituitarism in these patients.

- Identify risk factors for developing obesity and correlate the neurotransmitter concentration of leptin and neuropeptide Y in cerebral spinal fluid, serum, and craniopharyngioma cystic fluid with the likelihood of developing obesity in these patients.

- Determine the incidence and extent of eating disorders in these patients.

OUTLINE: This is a multicenter study.

Patients undergo neurologic, endocrine, and ophthalmologic tests and anthropometric diagnostic measurements. Patients then undergo 1 of the following surgical procedures: total resection; incomplete, subtotal, or partial resection; biopsy; or cyst pressure release. Patients whose tumor relapses may undergo a second resection and/or radiotherapy.

Quality of life is assessed at baseline and then periodically thereafter.

After surgery, patients are followed periodically.

PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.


Recruitment information / eligibility

Status Completed
Enrollment 120
Est. completion date September 2009
Est. primary completion date September 2007
Accepts healthy volunteers No
Gender Both
Age group N/A to 18 Years
Eligibility DISEASE CHARACTERISTICS:

- Diagnosis of primary craniopharyngioma by MRI and CT scan (initial diagnosis)

- Patients with only cystic sellar or parasellar malformation (e.g., Rathke pouch cysts or suprasellar cysts) are allowed but will undergo observation only

PATIENT CHARACTERISTICS:

Performance status

- Not specified

Life expectancy

- Not specified

Hematopoietic

- Not specified

Hepatic

- Not specified

Renal

- Not specified

PRIOR CONCURRENT THERAPY: Not specified

Study Design

Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


Intervention

Other:
metabolic assessment

physiologic testing

Procedure:
biopsy

computed tomography

conventional surgery

magnetic resonance imaging

management of therapy complications

psychosocial assessment and care

quality-of-life assessment

Radiation:
radiation therapy


Locations

Country Name City State
Austria Krankenhaus Dornbirn Dornbirn
Austria Landeskrankenhaus Feldkirch Feldkirch-Tisis
Austria Universitaet Kinderklinik Graz
Austria Innsbruck Universitaetsklinik Innsbruck
Austria Landeskrankenhaus Klagenfurt Klagenfurt
Austria LKH Leoben Leoben
Austria A. oe. Krankenhaus der Barmherzigen Schwestern Kinderabteilung Linz
Austria Landes-Kinderkrankenhaus Linz
Austria St. Johanns-Spital Salzburg
Austria Kardinal Schwarzenbersches Krankenhaus Betriebsgesellschraft mbH Kinderspital Schwarzach
Austria A. oe. Landeskrankenhaus Abt. fuer Kinderkrankheiten Steyr
Austria St. Anna Children's Hospital Vienna
Austria Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik Wien
Germany Kinderklinik - Universitaetsklinikum Aachen Aachen
Germany Klinikum Augsburg Augsburg
Germany Caritas-Krankenhaus Bad Mergentheim Bad Mergentheim
Germany Klinikum am Bamberg Bamberg
Germany Klinikum Bayreuth Bayreuth
Germany Charite - Campus Charite Mitte Berlin
Germany Charite University Hospital - Campus Virchow Klinikum Berlin
Germany Helios Klinikum Berlin Berlin
Germany Evangelisches Krankenhauus Bielfeld Biefeld
Germany Kinderklinik der Universitaet Bonn Bonn
Germany Klinikum Bremen-Mitte Bremen
Germany Allgemeinen Krankenhaus Celle Kinderklinik Celle
Germany Klinikum Chemnitz gGmbH Chemnitz
Germany Klinikum Coburg Coburg
Germany Children's Hospital Cologne
Germany Kliniken der Stadt Koeln gGmbH - Kinderkrankenhaus Riehl Cologne
Germany Carl - Thiem - Klinkum Cottbus Cottbus
Germany Vestische Kinderklinik Universitaetsklinik Witten/Herdecke Datteln
Germany Klinikum Lippe - Detmold Detmold
Germany Staedtisches Krankenhaus Dresden - Neustadt Dresden
Germany Universitatsklinikum Carl Gustav Carus Dresden
Germany Klinikum Duisburg Duisburg
Germany Klinikum Erfurt Erfurt
Germany Universitaets - Kinderklinik Erlangen
Germany Klinikum der J.W. Goethe Universitaet Frankfurt
Germany Universitaetskinderklinik - Universitaetsklinikum Freiburg Freiburg
Germany Kinderklinik Giessen
Germany Universitaetsklinikum Goettingen Goettingen
Germany Universitats - Kinderklinik Greiswald
Germany Kreiskrankenhaus Gummersbach GMBH Gummersbach
Germany Universitaetsklinikum Halle Halle
Germany University Medical Center Hamburg - Eppendorf Hamburg
Germany Medizinische Hochschule Hannover Hannover
Germany Kreskrankenhaus Kinderabteilung Heide
Germany Universitaets-Kinderklinik Heidelberg Heidelberg
Germany SLK - Kliniken Heilbronn GmbH - Klinikum am Gesundbrunnen Heilbronn
Germany Gemeinschaftskrankenhaus Herdecke
Germany Staedtisches Krankenhaus Hildesheim Hildesheim
Germany Universitaetsklinikum des Saarlandes Homburg
Germany Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein
Germany Universitaets - Kinderklinik Jena
Germany Municipal Hospital Complex of the University Kaiserslautern
Germany Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe
Germany Klinikum Kassel Kassel
Germany Staedtisches Krankenhaus Kiel Kiel
Germany University Hospital Schleswig-Holstein - Kiel Campus Kiel
Germany Klinikum Kemperhof Koblenz Koblenz
Germany Klinik Konstanz Konstanz
Germany Klinikum Krefeld GmbH Krefeld
Germany Kinderkrankenhaus St. Marien Landshut
Germany Universitaets - Kinderklinik Leipzig
Germany St. Annastift Krankenhaus Ludwigshafen
Germany Universitaets - Kinderklinik - Luebeck Luebeck
Germany Universitatsklinikum der MA Magdeburg
Germany Johannes Gutenberg University Mainz
Germany Staedtisches Klinik - Kinderklinik Mannheim
Germany Universitaets - Kinderklinik Marburg
Germany Klinikum Minden Minden
Germany Krankenhaus Neuwerk Klinik fuer Kinder und Jugendmedizin Moenchengladbach
Germany Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster Muenster
Germany Dr. von Haunersches Kinderspital der Universitaet Muenchen Munich
Germany Krankenhaus Muenchen Schwabing Munich
Germany Staedtisches Krankenhaus Muenchen - Harlaching Munich
Germany Klinikum Neubrandenburg Neubrandenburg
Germany Lukaskrankenhaus Neuss Neuss
Germany Marienhaus Klinikum St. Elisabeth Neuwied Neuwied
Germany Cnopf'sche Kinderklinik Nuremberg
Germany Klinikum Nuernberg - Klinikum Sued Nuremberg
Germany Klinikum Oldenburg Oldenburg
Germany Marien Hospital Osnabruck
Germany Paracelsus - Klinik Osnabrueck Osnabrueck
Germany Klinik St. Hedwig-Kinderklinik Regensburg
Germany Kinderklinik - Universitaetsklinikum Rostock Rostock
Germany Saarbrucker Winterbergkliniken Saarbrucken
Germany Klinikum Schwerin Schwerin
Germany Kinderklink Siegen Deutsches Rotes Kreuz Siegen
Germany Johanniter-Kinderklinik St. Augustin
Germany Olgahospital Stuttgart
Germany Krankenanstalt Mutterhaus der Borromaerinnen Trier
Germany Universitaetsklinikum Tuebingen Tuebingen
Germany Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm
Germany St. Marienhospital - Vechta Vechta
Germany Staedtisches Klinikum - Howedestrase Vechta
Germany Dr. Horst-Schmidt-Kliniken Wiesbaden
Germany Reinhard-Nieter-Krankenhaus Wilhelmshaven
Germany Klinikum der Stadt Wolfsburg Wolfsburg
Germany Universitaets - Kinderklinik Wuerzburg Wuerzburg
Germany Helios Kliniken Wuppertal University Hospital Wuppertal
Sweden Lanssjukhuset Ryhov Jonkoping
Switzerland Kantonspital Aarau Aarau
Switzerland Universitaets-Kinderspital beider Basel Basel
Switzerland Ospedale "la Carita", Locarno Locarno
Switzerland Kinderspital Luzern Lucerne 16
Switzerland Ostschweizer Kinderspital St. Gallen
Switzerland Kantonsspital Winterthur Winterthur
Switzerland University Children's Hospital Zurich

Sponsors (1)

Lead Sponsor Collaborator
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany

Countries where clinical trial is conducted

Austria,  Germany,  Sweden,  Switzerland, 

References & Publications (2)

Müller HL, Gebhardt U, Schröder S, Pohl F, Kortmann RD, Faldum A, Zwiener I, Warmuth-Metz M, Pietsch T, Calaminus G, Kolb R, Wiegand C, Sörensen N; study committee of KRANIOPHARYNGEOM 2000/2007. Analyses of treatment variables for patients with childhood — View Citation

Roth CL, Gebhardt U, Müller HL. Appetite-regulating hormone changes in patients with craniopharyngioma. Obesity (Silver Spring). 2011 Jan;19(1):36-42. doi: 10.1038/oby.2010.80. Epub 2010 Apr 8. — View Citation

See also
  Status Clinical Trial Phase
Terminated NCT00788125 - Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Phase 1/Phase 2
Completed NCT00006080 - Fenretinide in Treating Patients With Recurrent Malignant Glioma Phase 2
Recruiting NCT00887146 - Radiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade Glioma Phase 3
Suspended NCT00935090 - 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer N/A
Completed NCT00621686 - Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme Phase 2
Terminated NCT00227032 - Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme Phase 1
Completed NCT00112502 - Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme Phase 2
Terminated NCT00243022 - Dietary, Herbal and Alternative Medicine in Glioblastoma Multiforme Phase 2
Active, not recruiting NCT00087815 - Hyperbaric Oxygen Therapy in Treating Patients With Radiation Necrosis of the Brain N/A
Active, not recruiting NCT00278278 - Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas Phase 3
Completed NCT00416819 - Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma N/A
Completed NCT00052286 - Modafinil in Treating Fatigue and Behavioral Change in Patients With Primary Brain Cancer N/A
Completed NCT00006093 - EMD 121974 in Treating Patients With Progressive or Recurrent Glioma Phase 1/Phase 2
Recruiting NCT00004129 - Phosphorus 32 in Treating Patients With Glioblastoma Multiforme Phase 1
Completed NCT00004212 - DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas Phase 1
Completed NCT00003417 - Computer Planned Radiation Therapy Plus Chemotherapy in Treating Patients With Glioblastoma Multiforme Phase 1/Phase 2
Completed NCT00008008 - Thiotepa Followed by Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Malignant Glioma Phase 2
Completed NCT00003173 - High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors Phase 2
Completed NCT00003464 - Temozolomide in Treating Adults With Newly Diagnosed Primary Malignant Glioblastoma Multiforme Phase 2
Completed NCT00003484 - Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors Phase 1